°¡Àå È¿°ú ÁÁÀº Ç×±Õ¼º ¿Ü¿ëÁ¦

3 ¼ººÐ º¹ÇÕÁ¦
ÇǺΰ¨¿°¿¡ »ç¿ëµÇ´Â ±¹¼Ò¿ë Ç×±ÕÁ¦Áß
¼¼ ¼ººÐ º¹ÇÕÁ¦°¡ ´Ü¿¬ ¿ì¼öÇÏ´Ù
Neomycin °ú
Bacitracin °ú
Polymixin B º¹ÇÕÁ¦´Ù
ÀÌ´Â Àǻ縦 ´ë»óÀ¸·ÎÇÑ
ÃÖ½ÅÀÇ ¹ÌÁÖÁö¿ª º¸¼ö±³À°À»ÅëÇØ
¹ßÇ¥µÈ ³»¿ëÀÌ´Ù

Folliculitis(¸ð³¶¿°) Impetigo(³ó°¡Áø) Ecthyma(½ÉºÎ ³ó°¡Áø)
Erysipelas(´Üµ¶) Lymphangitis(Àӯİü¿°) Cellulitis(ºÀ¼ÒÁ÷¿°)
Furuncle(Á¾±â) Carbuncles(¿©·¯ °÷ÀÇ Á¾±â)
¼¼°è ¾î´À ³ª¶ó³ª ¸¶Âù°¡Áö

¾Æ¿ï·¯
NeomycinÀ» ÇÔÀ¯ÇÑ 3Áß º¹ÇÕÁ¦°¡
Àü ¼¼°è ¾î´À ³ª¶ó¿¡¼³ª
°¡Àå ¿ì¼öÇÑ ¿Ü¿ëÁ¦·Î »ç¿ëµÉ¼öÀÕÀ½À»
°Á¶Çϰí ÀÖ´Ù
»Ó¸¸¾Æ´Ï¶ó
ÇǺΠ°ú¹Î¹ÝÀÀÀ» ÀÏÀ¸ÄÑ
Á¢Ã˼º ÇǺο°À» À¯¹ßÇÑ´ÙÇÏ¿©
Áö±Ý±îÁö °æ¿ø½Ã µÇ¾î ¿Â NeomycinÀÌ
ÀüÇô ±×·¸Áö ¾Ê´Ù´Â »ç½Ç±îÁö ÀÔÁõÇÏ¿´´Ù
ÇǺΰ¨¿° ÁÖ¿ªÀº 4°¡Áö ±Õ
±×¶÷(+)±Õ
±×¶÷(-)±Õ
ÃÖ½ÅÀÇ ¼¼°èÀû Åë°è ÀÚ·á¿¡ÀÇÇϸé
ÇǺμ¼±Õ°¨¿°À» ÀÏÀ¸Å°´Â ÁÖ¿ªÀº
¾î´À ³ª¶ó¸¦ ¸··ÐÇϰí
4°¡Áö ±Õ¿¡ ±¹ÇѵȴÙ
ÃÖ°í ºóµµÀÇ ÇǺΰ¨¿°±Õ Æ÷µµ±¸±Õ
±×¶÷¾ç¼º±Õ¿¡¼´Â
Æ÷µµ»ó ±¸±Õ °ú ¿¬¼â»ó±¸±ÕÀ̰í
±×¶÷À½¼º ±Õ¿¡¼´Â
´ëÀå±Õµî °ú ³ì³ó±ÕÀÌ´Ù
±×¶÷(-) ´ëÀå±Õ
Enterococcus faecalis
±Õ°Ë»ç¸¦ ÇÏÁö ¾Ê°í »ç¿ëÇÒ ¶§
ÀÌ ³× °¡Áö ±ÕÀÌ ÀÏÀ¸Å°´Â
ÇǺΠ°¨¿°À» Ä¡·áÇϱâ À§ÇØ
±Õ°Ë»ç¸¦ ÇÏÁö ¾Ê°í
¿Ü¿ë¾àÀ» ¼±ÅÃÇÏ·Á¸é
³ó°¡Áø(Impetigo)
±×¶÷ ¾ç¼º±Õ°ú ±×¶÷À½¼º±ÕÀ»
¸ðµÎ Á¦°ÅÇÒ ¼ö ÀÖ´Â °ÍÀ̾î¾ß ÇÑ´Ù
Mupirocin
µû¶ó¼ ±×¶÷¾ç¼º±Õ¿¡¸¸ µè´Â
MupirocinÀº ´ç¿¬ Á¦¿ÜµÇ¾ßÇÑ´Ù
Äû³ë·Ð°è Ç×±ÕÁ¦
³»¼º À¯¹ß °úÁ¤
¶ÇÇÑ
±¤¹üÀ§Ç×±ÕÁ¦Áß¿¡¼µµ
Äû³ë·Ð°è Ç×±ÕÁ¦´Â
³»¼ºÀÌ Àß À¯¹ßÇÑ´ÙÇÏ¿©
ºñ±³Æò°¡¿¡¼ Á¦¿ÜµÇ¾ú´Ù


±¤¹üÀ§Çϸ鼵µ
¿Ü¿ëÁ¦·Î »ç¿ë½Ã
³»¼ºÀ» °¡Àå Àß ÀÏÀ¸Å°Áö ¾Ê´Â
Neomycin °ú
Bacitracin °ú
PolymixinÀ» ´ë»óÀ¸·Î ÇÏ¿©
ºñ±³ Æò°¡ÇÑ °á°ú´Â ´ÙÀ½°ú °°´Ù

³ó°¡Áø(Impetigo)
|
A
Neomycin |
B
Bacitracin |
C
Polymixin |
A+B |
A+C |
B+C |
A
+B+C |
| Æ÷µµ±¸±Õ |
1 |
54 |
61 |
»ó½Â |
»ó°¡ |
»ó°¡ |
»ó½Â |
| Àå³»±¸±Õ |
16 |
108 |
975 |
»ì°¡ |
»ó½Â |
»ó°¡ |
»ó½Â |
| ´ëÀå±Õ |
8 |
>6917 |
1 |
»ó°¡ |
»ó°¡ |
»ó°¡ |
»ó½Â |
| ³ì³ó±Õ |
32 |
>6917 |
8 |
»ó½Â |
»ó°¡ |
»ó½Â |
»ó½Â |
¼ýÀÚ: MIC ³óµµ
Neomycin
Bacitracin
Polymixin-B
¾ÆÅäÇǼº ÇǺο° ÀÇ °¨¿°

¾ÆÅäÇǼº ÇǺο°ÀÌ ³Ä¡ÈµÇ´Â °ÍÀº
³»¼º Æ÷µµ±¸±ÕÀÌ °¨¿°µÇ±â ¶§¹®ÀÌ´Ù

3 ¼ººÐ º¹ÇÕÁ¦´Â MRSA ³»¼º Æ÷µµ±¸±Õ °ú
Mupirocin ³»¼ºÆ÷µµ±¸±Õ 25±ÕÁ¾¿¡´ëÇØ
MICº¯È¾øÀÌ »ì±ÕÇÑ´Ù
Neomycin¿¡´ëÇÑ ¿ÀÇØ
NeomycinÀº Aminoglycoside°è Ç×±ÕÁ¦´Ù
±×¶÷¾ç¼º°ú ±×¶÷ À½¼º¿¡ ±¤¹üÀ§ÇÏ°Ô µè´Â Ç×±ÕÁ¦´Ù
½ÉºÎ³ó°¡Áø(Ecthyma)
±×·¯³ª °ú¹Î¹ÝÀÀ¿¡ÀÇÇÑ À̸¥¹Ù Á¢Ã˼º ÇǺο°À» ÀÏÀ¸Å²´Ù´Â
°ú°ÅÀÇ À߸øµÈ º¸°í·Î ÀÎÇØ
»ç¿ëÀ» °ÅÀÇ ±âÇÇÇØ¿Â Ç×±ÕÁ¦´Ù
Á¢Ã˼º ÇǺο°
±×·¯³ª
2175¸í(18-25¼¼)À» ´ë»óÀ¸·ÎÇÑ ÀÓ»óÀ» ÅëÇØ
ÀüÇô »ç½Ç ¹«±ÙÀÓÀÌ ¹àÇôÁ³´Ù
.jpg)
|
Á¢Ã˼º¾Ù·¯Áö¹ÝÀÀ |
ºñ¾Ù·¯Áö¹ÝÀÀ |
|
20% Neomycin
Skin Test |
0.09% |
0.9% |
¶ÇÇÑ ¼Ò¾Æ 653¸íÀ» ´ë»óÀ¸·ÎÇÑ ½ÇÇè¿¡¼´Â Skintest¿¡¼
98¸íÀÌ ¾ç¼ºÀ̾ú´Ù
±×·¯³ª À̵鿡°Ô Neomycin¿Ü¿ëÁ¦¸¦ »ç¿ëÇßÀ» ¶§ ´Ü 1¸í¸¸ÀÌ
Á¢Ã˼º ¾Ù·¯Áö ¹ÝÀÀÀ» ³ªÅ¸³»¾ú´Ù
À̿ܿ¡µµ ¸î °¡Áö ´ëÇü ÀÓ»ó ¸ðµÎ°¡ Á¢Ã˼º ¹ÝÀÀÀÌ °ÅÀÇ ¾øÀ½À»
³ªÅ¸³»°íÀÕ´Ù

¿¹¹æ¿ë Ç×±Õ ¿ä¹ý
ÇǺο¡ ¹Ù¸£´Â Ç×±Õ¼º ¿Ü¿ë¾àÀº
°¨¿° ¿¹¹æ¿ëÀ¸·Î °¡Àå ¸¹ÀÌ »ç¿ëµÈ´Ù
»óó°¡ ³ª°Å³ª ¼ö¼úÇÑÀÚ¸®¸¦
¿Ü°úÀûÀ¸·Î µå·¹½ÌÇÑÈÄ
±×´ë·Î ³ëÃâ½ÃÄѳõÀ¸¸é
µüÁö°¡ »ý±â¹Ç·Î
»õ ÇǺΰ¡ µ¸¾Æ³ª·Á¸é 3ÁÖ³ª °É¸°´Ù

±×·¯³ª
µå·¹½ÌÈÄ °¡Á¦ µîÀ¸·Î µ¤¾î³õÀ¸¸é
1ÁÖ¸¸ ÇǺΰ¡ Àç»ýÇÑ´Ù
ÇÏÁö¸¸
µ¤¾î ³õÀ¸¸é ½À±â°¡ Â÷¼
º´±ÕÀÌ Áõ½ÄÇϸé
ÇǺΠ°¨¿°À» ÀÏÀ¸Å°±â½±»óÀÌ´Ù
¶§¹®¿¡ Ç×±Õ¼º ¿Ü¿ëÁ¦¸¦ ¹ß¸¥´Ù

ÇѱÕÁ¦¸¦ ¹Ù¸£¸é µ¤¾î³õ´Â
µüÁö°¡ »ý±â´Â °Íµµ ¸·À»¼öÀÕ´Ù
°¡Á¦·Î µ¤´Â °æ¿ìº¸´Ù
ÇǺÎÀÇ »ö»ó º¯È°±Û 38%ÀÌ»ó ¹æÁöÇØÁØ´Ù
Ãâ»ê¾Æ ÅÈÁÙ cutting
¾ËÄÚ¿Ã ¼Òµ¶Àº Àç°íµÇ¾ßÇÑ´Ù
ÇǺΠÀÚ¸¥ ÀÚ¸®³ª »óóÀÚ¸®¿¡
¾ËÄڿ÷Π¼Òµ¶ÇÏ´Â °ÍÀº À§ÇèÇÏ´Ù
ÇǺθ¦ ÀÚ±ØÇÏ°í »óó ȸº¹À» Áö¿¬½Ã۱⠶§¹®ÀÌ´Ù
[±Ù°Å]
The Role of Topical Antibiotics in Dermatologic Practice CME
Author: J.J. Leyden, MD Professor Emeritus, Dermatology,
University of Pennsylvania, Philadelphia; Professor of
Dermatology, University of Pennsylvania Hospital, Philadelphia;
June 25, 2003; Valid through June 25, 2004; for physicians and nurses.;
accredited by the Accreditation Council for Continuing Medical
Education (ACCME) to provide continuing medical education
for physicians; The American Medical Association has determined
that non-US licensed physicians who participate in this CME
activity are eligible for AMA PRA category 1 credit.
Medscape's CME/CE activity.